|1 to 10 of 477||Next||Last|
The Department of Health and Human Services (HHS) announces the Dec. 19th Federal Register publication of the notice of proposed rulemaking (NPRM) CMS-0054-P pertaining to the Administrative Simplification provisions of the Health Insurance Portability and Accountability Act of 1996 (HIPAA).
The Department of Health and Human Services, through the Centers for Medicare & Medicaid Services (CMS), announces and seeks public input on a new “International Pricing Index” (IPI) payment model to reduce what Americans pay for prescription drugs.
The program supports research to test optimal end-of-life and palliative care interventions and models of care based on individual- and family-centered outcomes. NIH is especially interested in interventions and models addressing racial, ethnic and cultural diversity in children and adults for those with serious, advanced illness.
GAO asserts its findings “are consistent with CMS’s monitoring results, which indicate that there were no widespread effects on beneficiary access in the year after the adjusted rates went into effect.” The GAO's findings fly directly in the face of the DME industry's claims as well as a study the industry commissioned earlier this year.
The Food and Drug Administration has just approved the first-ever generic version of the EpiPen and EpiPen Jr (epinephrine) auto-injector for the emergency treatment of allergic reactions, including those that are life-threatening (anaphylaxis), in adults and pediatric patients who weigh more than 33 pounds.
After taking several months to rearrange the Consumer Financial Protection Bureau and rid it of what Acting Director Mick Mulvaney considered onerous regulations and enforcement strategies, Mulvaney moves to settle several investigations into financial firms using a carrot rather than a stick.
The Food & Drug Administration (FDA) has released its long-awaited Biosimilar Action Plan. The release became public Wednesday (July 18) during a speech by FDA Commissioner Scott Gottlieb in Washington, DC. Biosimilars are biologic medical products which are almost an identical copies of original products manufactured by different companies.
The Internal Revenue Service reminded taxpayers to be careful with continuing aggressive phone scams as criminals pose as IRS agents in hopes of stealing money. These continuing phone calls remain a major threat to taxpayers -- especially older taxpayers -- and remain on the annual IRS "Dirty Dozen" list of tax scams for the 2018 filing season.
The Centers for Medicare & Medicaid Services (CMS) released new federal nursing facility regulations in 2016. The vast majority of the regulations became effective in November 2016, but some components are newly effective as of November 2017.
The Centers for Medicare & Medicaid Services (CMS) has taken immediate steps and is monitoring conditions in support of California residents displaced and recovering from the wildfires ravaging southern portions of the state.
|1 to 10 of 477||Next||Last|